Article Information
History
- October 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Cyrielle Maroteau1,2,*,
- Antonio Espuela-Ortiz3,
- Esther Herrera-Luis3,
- Sundararajan Srinivasan2,
- Fiona Carr2,
- Roger Tavendale2,
- Karen Wilson2,
- Natalia Hernandez-Pacheco3,4,
- James D. Chalmers5,
- Steve Turner6,
- Somnath Mukhopadhyay7,
- Anke-Hilse Maitland-van der Zee8,9,10,
- Esteban G. Burchard11,12,
- Maria Pino-Yanes3,13,14,
- Simon Young15,
- Glenda Lassi16,
- Adam Platt16,
- Colin N. A. Palmer2,
- on behalf of the PiCA consortium
- 1Centre for Genomics Research, Discovery Science, BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
- 2Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, U.K.
- 3Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristobal de La Laguna, Santa Cruz de Tenerife, Spain
- 4Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, Spain
- 5Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, U.K.
- 6Child Health, University of Aberdeen, Aberdeen, U.K.
- 7Academic Department of Pediatrics, Brighton and Sussex Medical School, Royal Alexandra Children’s Hospital, Brighton, U.K.
- 8Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands
- 9Department of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, the Netherlands
- 10Department of Pediatric Respiratory Medicine and Allergy, Emma’s Children Hospital, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
- 11Department of Medicine, University of California, San Francisco, San Francisco, California, United States
- 12Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States
- 13CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Comunidad de Madrid, Spain
- 14Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain
- 15BioPharmaceutical Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, U.K.
- 16Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, U.K.
- ↵*Correspondence:
Cyrielle Maroteau, PhD, Postdoctoral researcher, Centre for Genomics Research, Discovery Science, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom, Phone: +441382383155, E-mail: cyrielle.maroteau{at}astrazeneca.com